WELLS FARGO & COMPANY/MN - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 50 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$104,000
-86.2%
103,500
-86.2%
0.00%
Q2 2021$756,000
-16.6%
752,500
-15.8%
0.00%
Q1 2021$906,000
-11.1%
893,500
-5.3%
0.00%
Q4 2020$1,019,000
-2.1%
943,500
-6.4%
0.00%
Q3 2020$1,041,000
-11.3%
1,007,500
-5.3%
0.00%
Q2 2020$1,173,000
+6.5%
1,064,000
-2.2%
0.00%
Q1 2020$1,101,000
-58.0%
1,088,000
-52.6%
0.00%
-100.0%
Q4 2019$2,624,000
-69.7%
2,293,000
-69.8%
0.00%
-50.0%
Q3 2019$8,653,000
+167.0%
7,587,000
+176.9%
0.00%
+100.0%
Q2 2019$3,241,000
-61.7%
2,740,000
-56.3%
0.00%
-66.7%
Q1 2019$8,467,000
+488.8%
6,264,000
+366.1%
0.00%
Q4 2018$1,438,000
-0.1%
1,344,000
-2.0%
0.00%
Q3 2018$1,440,000
-70.5%
1,372,000
-72.4%
0.00%
-100.0%
Q2 2018$4,885,000
-63.4%
4,972,000
-63.2%
0.00%
-75.0%
Q1 2018$13,347,000
+207.6%
13,510,000
+228.7%
0.00%
+300.0%
Q4 2017$4,339,000
-8.5%
4,110,000
-8.4%
0.00%0.0%
Q3 2017$4,740,000
-62.5%
4,487,000
-62.4%
0.00%
-75.0%
Q2 2017$12,653,000
+6.0%
11,930,000
-3.7%
0.00%0.0%
Q1 2017$11,933,000
+547.8%
12,390,000
+580.4%
0.00%
+300.0%
Q4 2016$1,842,000
+1969.7%
1,821,000
+1777.3%
0.00%
Q3 2016$89,000
-98.9%
97,000
-99.2%
0.00%
-100.0%
Q2 2016$8,141,000
+171.5%
11,468,000
+245.6%
0.00%
+200.0%
Q1 2016$2,999,000
-33.7%
3,318,000
-17.0%
0.00%
-50.0%
Q4 2015$4,522,0004,000,0000.00%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC DEL in Q1 2020.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders